Delivery Order SPE2DB20D1109-SPE2DB23FP56S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,191.98 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used to treat diabetes. The contract has an ultimate completion date of January 27, 2023 and was awarded on January 26, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,571.20 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, which is a medication used to treat diabetes. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which enables the company to deliver a wide range of pharmaceutical...
- This federal contract award is a delivery order, valued at $3,026.32, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a prescription medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,231.96 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, which is a medication commonly used to treat diabetes. The contract has an ultimate completion date of November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This federal contract award, valued at $10,656.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty medication used to manage diabetes. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,269.80, is for the delivery of Lantus Solostar 100 Unit/mL 3mL, a specialty pharmaceutical product used for the management of diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,223.76 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award, with a value of $1,384.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/ml 3ml medication. The contract has a ceiling value of $1,180.08 and an ultimate completion date of August 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical for up to $999,999,999.00 to provide a...
- This federal contract award, valued at $2,223.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The award was made under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP56SDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,268.36 firm-fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for the management of diabetes. The contract has an ultimate completion date of July 20, 2023 and was awarded on July 19, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/19/23 |